Your browser doesn't support javascript.
loading
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
Kirk, Peter S; Lotan, Yair; Zargar, Homayoun; Fairey, Adrian S; Dinney, Colin P; Mir, Maria C; Krabbe, Laura-Maria; Cookson, Michael S; Jacobson, Niels-Erik; Montgomery, Jeffrey S; Vasdev, Nikhil; Yu, Evan Y; Xylinas, Evanguelos; Kassouf, Wassim; Dall'Era, Marc A; Sridhar, Srikala S; McGrath, Jonathan S; Aning, Jonathan; Shariat, Shahrokh F; Thorpe, Andrew C; Morgan, Todd M; Holzbeierlein, Jeff M; Bivalacqua, Trinity J; North, Scott; Barocas, Daniel A; Grivas, Petros; Garcia, Jorge A; Stephenson, Andrew J; Shah, Jay B; Daneshmand, Siamak; Spiess, Philippe E; van Rhijn, Bas W G; Mertens, Laura; Black, Peter; Wright, Jonathan L.
Afiliación
  • Kirk PS; Department of Urology, University of Washington, Seattle, Washington.
  • Lotan Y; Department of Urology, University of Texas Southwestern, Dallas, Texas.
  • Zargar H; Department of Urology, Western Health, Melbourne, Australia.
  • Fairey AS; USC/Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, California.
  • Dinney CP; University of Alberta, Edmonton, Alberta, Canada.
  • Mir MC; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
  • Krabbe LM; Department of Urology, Fundacio Instituto Valenciano de Oncologia, Valencia, Spain.
  • Cookson MS; Department of Urology, University of Münster, Münster, Germany.
  • Jacobson NE; Department of Urology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma.
  • Montgomery JS; University of Alberta, Edmonton, Alberta, Canada.
  • Vasdev N; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan.
  • Yu EY; Department of Urology, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital, Stevenage, United Kingdom.
  • Xylinas E; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom.
  • Kassouf W; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Dall'Era MA; Fred Hutchinson Cancer Center, Seattle, Washington.
  • Sridhar SS; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, New York.
  • McGrath JS; Division of Urology, Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada.
  • Aning J; Department of Urology, University of California at Davis, Davis Medical Center, Sacramento, California.
  • Shariat SF; Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Thorpe AC; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom.
  • Morgan TM; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom.
  • Holzbeierlein JM; Department of Surgery, Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Trust, Exeter, United Kingdom.
  • Bivalacqua TJ; Department of Urology, University of Texas Southwestern, Dallas, Texas.
  • North S; Department of Urology, Weill Cornell Medical College, Presbyterian Hospital, New York, New York.
  • Barocas DA; Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Grivas P; Department of Urology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom.
  • Garcia JA; Department of Urology, University of Michigan Health System, Ann Arbor, Michigan.
  • Stephenson AJ; Department of Urology, University of Kansas Medical Center, Kansas City, Kansas.
  • Shah JB; Department of Urology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Daneshmand S; Division of Urology, Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Spiess PE; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
  • van Rhijn BWG; Division of Oncology, Department of Medicine, University of Washington, Seattle, Washington.
  • Mertens L; Fred Hutchinson Cancer Center, Seattle, Washington.
  • Black P; Case Comprehensive Cancer Center, Cleveland, Ohio.
  • Wright JL; Department of Urology, Rush University, Chicago, Illinois.
J Urol ; 209(5): 882-889, 2023 05.
Article en En | MEDLINE | ID: mdl-36795962
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Urol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Urol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos